Allogeneic Haemopoietic Stem Cell Transplantation for Multiple Myeloma or Plasma Cell Leukaemia Using Fractionated Total Body Radiation and High-dose Melphalan Conditioning

By Russell Nigel   Bessell Eric   Stainer Claire   Haynes Andrew   Das-Gupta Emma   Byrne Jenny  

Acta Oncologica, Vol. 39, Iss. 7, 2000-11 ,pp. : 837-841

Informa Healthcare

Access to resources Recommend Favorite

High-dose Melphalan with Re-infusion of Unprocessed, G-CSF-primed Whole Blood is Effective and Non-toxic Therapy in Multiple Myeloma

By Ossenkoppele G.J.   Schuurhuis G.J.   Jonkhoff A.R.   van der Hem K.G.   Legdeur M.C.J.C.   Boot-Bakker A.   Westra A.H.   Drager A.M.   Huijgens P.C.  

European Journal of Cancer, Vol. 32, Iss. 12, 1996-11 ,pp. : 2058-2063

Elsevier

Access to resources Recommend Favorite

Health-Related Quality of Life in Multiple Myeloma Patients Receiving High-Dose Chemotherapy with Autologous Blood Stem-Cell Support

By Gulbrandsen N.   Wisløff F.   Brinch L.   Carlson K.   Dahl I.M.   Gimsing P.   Hippe E.   Hjorth M.   Knudsen L.M.   Lamvik J.   Lenhoff S.   Løfvenberg E.   Nesthus I.   Lanng Nielsen J.   Turesson I.   Westin J.  

Medical Oncology, Vol. 18, Iss. 1, 2001-03 ,pp. : 65-77

Humana Press, Inc

Access to resources Recommend Favorite

Infusional Mitoxantrone Plus Bolus Melphalan as a Stem Cell Transplant Conditioning Regimen for Multiple Myeloma

By Beaven Anne W.   Moore Dominic T.   Sharf Andrew   Serody Jonathan S.   Shea Thomas C.   Gabriel Don A.  

Cancer Investigation, Vol. 29, Iss. 3, 2011-02 ,pp. : 214-219

Informa Healthcare

Access to resources Recommend Favorite

Treatment options for multiple myeloma patients with high-risk disease

By Ailawadhi Sikander   Masood Aisha   Sher Taimur   Miller Kena   Wood Margaret   Lee Kelvin   Chanan-Khan Asher  

Medical Oncology, Vol. 27, Iss. 1, 2010-06 ,pp. : 53-61

Humana Press, Inc

Access to resources Recommend Favorite